Is there a defined need for rapid response?
Examples may include research workflows, participant screening or other professional applications where shorter waiting time matters.
For time-sensitive settings
Connect rapid molecular testing capabilities
Q-VELOX Q100 is an automated Molecular POCT product provided by KDX Biotech. NovoBay helps assess application scenarios and organize collaboration around specific research, clinical and drug development needs.
Q-VELOX Q100
Automated Molecular POCT product
The product is designed to support rapid molecular testing through an integrated, automated workflow. The information below helps professional partners understand potential application value; specific metrics and conditions must be verified against KDX Biotech's complete product materials.
- Turnaround timeApproximately 3–4 hours in applicable testing workflows; actual timing depends on the project and operating conditions.
- Sample requirementsOne FFPE section may be used in defined applications, which can help reduce the use of precious samples.
- WorkflowAn integrated, automated design that may be evaluated for settings with limited laboratory conditions or decentralized deployment.
- Regulatory statusRegistration details, intended use and scope are subject to formal materials from KDX Biotech and the relevant regulators.
FIT QUESTIONSBegin with these conditions
Begin with these conditions
when assessing product fit
Product specifications should not be assessed separately from the intended setting. NovoBay first helps clarify timing, sample, workflow and evidence requirements.
Is sample material precious or limited?
Assess the practical value of low sample consumption alongside sample type, quality and downstream testing plans.
Do current laboratory conditions constrain deployment?
Assess whether staffing, space, equipment, quality management and ongoing support meet implementation requirements.
HOW WE COLLABORATE
How NovoBay participates
We do not replace the product owner in making technical or regulatory commitments. We help need owners and KDX Biotech coordinate information, assess scenarios and organize projects more efficiently.
Clarify the need
Confirm the disease area, sample conditions, intended application and key constraints.
Verify information
Coordinate appropriate product, performance and regulatory materials from the product owner.
Plan validation
Define the question to be assessed, workflow, resources and responsibility boundaries.
Project Advancement
Coordinate training, implementation, feedback and later collaboration under written arrangements.
This page does not constitute an offer to sell, clinical advice or a statement of regulatory approval. Any use of the product must follow formal instructions, applicable law and appropriate professional judgment.
Assess a Molecular POCT scenario
Share the intended use, sample conditions and workflow question you need to resolve.